Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 266 | $122,323,899 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
02 Jun 2023 16:14 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Jun 2023 | Sale | 10 | 734.62 | 7,346 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 9 | 820.5 | 7,384 | D |
03 Aug 2023 16:25 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2023 | Sale | 10 | 738.45 | 7,384 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 8 | 959.68 | 7,677 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 8 | 986.58 | 7,893 | D |
06 Jul 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jul 2023 | Sale | 11 | 719.36 | 7,913 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 9 | 892.5 | 8,032 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 9 | 897.68 | 8,079 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 9 | 901.46 | 8,113 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 10 | 826.62 | 8,266 | D |
06 Jul 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jul 2023 | Sale | 12 | 718.71 | 8,625 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 9 | 959.47 | 8,635 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 9 | 962.42 | 8,662 | D |
02 Jun 2023 16:14 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Jun 2023 | Sale | 12 | 735.42 | 8,825 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 10 | 902.37 | 9,024 | D |
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 11 | 827.65 | 9,104 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 10 | 949.48 | 9,495 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 10 | 955.35 | 9,554 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 10 | 960.52 | 9,605 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 10 | 985.76 | 9,858 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 11 | 982.67 | 10,809 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 13 | 903.49 | 11,745 | D |
03 Aug 2023 16:25 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2023 | Sale | 16 | 736.64 | 11,786 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 12 | 983.61 | 11,803 | D |
03 Aug 2023 16:25 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2023 | Sale | 17 | 737.5 | 12,538 | D |
02 Jun 2023 16:14 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Jun 2023 | Sale | 17 | 737.52 | 12,538 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 13 | 965.35 | 12,550 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 14 | 899.66 | 12,595 | D |
03 Aug 2023 16:25 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2023 | Sale | 18 | 734.56 | 13,222 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 14 | 961.59 | 13,462 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 15 | 960.53 | 14,408 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 15 | 981.64 | 14,725 | D |
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 18 | 825.53 | 14,860 | D |
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 18 | 829.43 | 14,930 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 17 | 898.51 | 15,275 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 19 | 804.89 | 15,293 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 19 | 805 | 15,295 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 16 | 964.45 | 15,431 | D |
06 Jul 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jul 2023 | Sale | 22 | 717.57 | 15,787 | D |
03 Aug 2023 16:25 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2023 | Sale | 22 | 735.55 | 16,182 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 17 | 966.3 | 16,427 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 19 | 953 | 18,107 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 19 | 984.45 | 18,705 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 20 | 963.6 | 19,272 | D |
06 Jul 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jul 2023 | Sale | 29 | 716.74 | 20,785 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 27 | 811.48 | 21,910 | D |
02 Jun 2023 16:14 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Jun 2023 | Sale | 31 | 736.4 | 22,828 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 29 | 900.59 | 26,117 | D |
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 39 | 828.54 | 32,313 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 46 | 840.74 | 38,674 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 47 | 961.74 | 45,202 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 58 | 814.06 | 47,215 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 78 | 965.51 | 75,310 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 103 | 811.37 | 83,571 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 95 | 945.81 | 89,852 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 100 | 947.34 | 94,734 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 112 | 949.07 | 106,296 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 136 | 810.38 | 110,212 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 138 | 835.67 | 115,322 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 148 | 839.28 | 124,213 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 155 | 815.97 | 126,475 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 167 | 813.66 | 135,881 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 150 | 948.7 | 142,305 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 184 | 821.46 | 151,149 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 204 | 797.79 | 162,749 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 182 | 951.92 | 173,249 | D |
06 Jul 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 03 Jul 2023 | Sale | 250 | 710.09 | 177,522 | D |
02 Jun 2023 16:12 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Jun 2023 | Sale | 250 | 736 | 184,000 | D |
03 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Aug 2023 | Sale | 250 | 744.66 | 186,165 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 23 Aug 2023 | Sale | 223 | 844 | 188,212 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 196 | 968.2 | 189,767 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 200 | 951.77 | 190,354 | D |
06 Sep 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Sep 2023 | Sale | 250 | 834.55 | 208,638 | D |
26 Dec 2023 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Controller | 22 Dec 2023 | Sale | 250 | 846.27 | 211,568 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 226 | 938.13 | 212,017 | D |
03 May 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 May 2024 | Sale | 250 | 889.41 | 222,352 | D |
12 Dec 2023 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 11 Dec 2023 | Sale | 270 | 838.44 | 226,379 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 240 | 947.81 | 227,474 | D |
04 Jan 2024 16:17 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 02 Jan 2024 | Sale | 274 | 873.91 | 239,451 | D |
03 Apr 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Apr 2024 | Sale | 250 | 964.73 | 241,182 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 300 | 837.53 | 251,259 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 23 Aug 2023 | Sale | 300 | 837.92 | 251,376 | D |
02 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Feb 2024 | Sale | 273 | 945.61 | 258,152 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 275 | 941.41 | 258,888 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 330 | 803.38 | 265,115 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 347 | 795.38 | 275,997 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 347 | 802.63 | 278,513 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 345 | 820.54 | 283,086 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 372 | 812.57 | 302,276 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 363 | 841.15 | 305,337 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 382 | 800.55 | 305,810 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 344 | 950.49 | 326,969 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Mar 2024 | Sale | 358 | 967.5 | 346,365 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 375 | 950.45 | 356,419 | D |
26 Dec 2023 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Controller | 21 Dec 2023 | Sale | 456 | 843.79 | 384,768 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 439 | 937.94 | 411,756 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 23 Aug 2023 | Sale | 500 | 841.05 | 420,525 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 444 | 952.4 | 422,866 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 477 | 958.34 | 457,128 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 487 | 951.39 | 463,327 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)